Journal
JCI INSIGHT
Volume 6, Issue 18, Pages -Publisher
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/jci.insight.151571
Keywords
-
Categories
Funding
- Fondation de France
- Fondation de France, Tous unis contre le virus
- Agence Nationale de la Recherche (ANR Flash COVID19 program)
- SARS-CoV-2 Program of the Faculty of Medicine from Sorbonne University (I-COVID programs)
- AG2R LA MONDIALE (Region IDF, France)
- Fondation pour la Recherche Medicale team award
- European Union's Horizon 2020 Research and Innovation Programme [681137]
- ANR Flash COVID19 program
Ask authors/readers for more resources
This study identified specific T cell populations associated with survival or death in COVID-19 patients in intensive care, providing potential targets for T cell-based vaccine development and disease outcome prediction.
The importance of the adaptive T cell response in the control and resolution of viral infection has been well established. However, the nature of T cell-mediated viral control mechanisms in life-threatening stages of COVID-19 has yet to be determined. The aim of the present study was to determine the function and phenotype of T cell populations associated with survival or death of patients with COVID-19 in intensive care as a result of phenotypic and functional profiling by mass cytometry. Increased frequencies of circulating, polyfunctional CD4(+)CXCR5(+)HLA-DR+ stem cell memory T cells (Tscms) and decreased proportions of granzyme B-expressing and perforinexpressing effector memory T cells were detected in recovered and deceased patients, respectively. The higher abundance of polyfunctional PD-L1(+)CXCR3(+)CD8(+) effector T cells (Teffs), CXCR5(+)HLA-DR+ Tscms, and anti-nucleocapsid (anti-NC) cytokine-producing T cells permitted us to differentiate between recovered and deceased patients. The results from a principal component analysis show an imbalance in the T cell compartment that allowed for the separation of recovered and deceased patients. The paucity of circulating PD-L1(+)CXCR3(+)CD8(+) Teffs and NC-specific CD8(+) T cells accurately forecasts fatal disease outcome. This study provides insight into the nature of the T cell populations involved in the control of COVID-19 and therefore might impact T cell-based vaccine designs for this infectious disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available